New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
10:03 EDTARMH, ONNN, CACI, PAL, VIPS, GEVA, FEYE, WWWW, YELP, WBC, NKE, MNK, HUBG, HAR, EL, LLY, ALGT, LGOn The Fly: Analyst Upgrade Summary
ARM Holdings (ARMH) upgraded to Market Perform from Underperform at Bernstein... Allegiant Travel (ALGT) upgraded to Buy from Hold at Deutsche Bank... Eli Lilly (LLY) upgraded to Market Perform from Underperform at BMO Capital... Estee Lauder (EL) upgraded to Outperform from Market Perform at Bernstein... Harman (HAR) upgraded to Strong Buy from Outperform at Raymond James...Hub Group (HUBG) upgraded to Buy from Hold at BB&T... Mallinckrodt (MNK) upgraded to Outperform from Market Perform at BMO Capital... Nike (NKE) upgraded to Buy from Hold at Stifel... S Ecology (ECOL) upgraded to Buy from Hold at KeyBanc... WABCO (WBC) upgraded to Conviction Buy from Buy at Goldman... Yelp (YELP) upgraded to Buy from Neutral at SunTrust... Web.com (WWWW) upgraded to Buy from Hold at Craig-Hallum... FireEye (FEYE) upgraded at Wedbush... Synageva (GEVA) upgraded at Wedbush... Vipshop (VIPS) upgraded to Outperform from Neutral at Credit Suisse... North American Palladium (PAL) upgraded to Sector Performer at CIBC... CACI International (CACI) upgraded to Outperform from Underperform at Raymond James... ON Semiconductor (ONNN) upgraded to Buy from Neutral at MKM Partners... Laclede (LG) upgraded to Buy from Hold at Stifel.
News For ARMH;ALGT;LLY;EL;HAR;HUBG;MNK;NKE;WBC;YELP;WWWW;FEYE;GEVA;VIPS;PAL;CACI;ONNN;LG From The Last 14 Days
Check below for free stories on ARMH;ALGT;LLY;EL;HAR;HUBG;MNK;NKE;WBC;YELP;WWWW;FEYE;GEVA;VIPS;PAL;CACI;ONNN;LG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 22, 2014
16:04 EDTWWWWWeb.com files to sell 213,200 shares of common stock for holders
Subscribe for More Information
09:02 EDTMNKMallinckrodt names Furey Chief Compliance Officer
Subscribe for More Information
August 21, 2014
15:16 EDTMNKDEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
13:00 EDTONNNOn The Fly: Midday Wrap
Subscribe for More Information
11:24 EDTNKEUnder Armour offered Durant $265M-$285M contract, ESPN reports
Subscribe for More Information
11:13 EDTONNNShares of Semtech up as Bloomberg says company positioned for good fortune
Subscribe for More Information
09:22 EDTFEYEFireEye has further downside, says Northland
Subscribe for More Information
08:30 EDTFEYEFireEye valuation attractive, says Goldman
Goldman views Buy rated FireEye's share price as an attractive entry point for best-in-class growth, attractive positioning, reset expectations, and positive industry themes.
08:04 EDTCACICACI awarded 'prime position' on $37M contract
CACI announced it has been selected as a prime contractor to provide logistics support to the U.S. Navy’s Military Sealift Command on the Worldwide Logistics Services contract. This five-year multiple-award indefinite delivery/indefinite quantity contract has a ceiling value of $37M and represents continuing work in CACI’s Logistics and Material Readiness market area. On the WLS contract, CACI will support MSC’s mission by providing fleet logistics operations, acquisition logistics, sustainment logistics, logistics systems and data management, ordnance management, and supply chain management, among other logistics services.
07:12 EDTLLYEli Lilly announces results from pivotal UNCOVER studies for ixekizumab
Eli Lilly announces that its investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies. Patients treated with both dosing regimens of ixekizumab had significantly greater levels of skin clearance compared to placebo and to etanercept at the 12-week endpoint. Skin clearance was measured by standard primary endpoints for psoriasis studies: the Psoriasis Area and Severity Index and the Static Physician Global Assessment. For patients treated with ixekizumab either every four weeks or every two weeks, between 78 to 90 percent of patients achieved at least a 75 percent reduction in PASI score at 12 weeks. Additionally, 31 to 41 percent of these patients achieved PASI 100, or clear skin, at week 12. For comparison, between 5 to 7 percent of patients treated with etanercept in the UNCOVER-2 and 3 studies achieved PASI 100. Adverse events were comparable for patients receiving ixekizumab in the 12-week, randomized control portion across all three studies.
07:09 EDTONNNInfineon deal positions Intersil, Semtech for good fortune, Bloomberg says
Subscribe for More Information
August 20, 2014
16:09 EDTCACICACI backs 2015 EPS view $5.10-$5.51, consensus $5.33
Subscribe for More Information
16:08 EDTCACICACI reports Q4 EPS $1.49, consensus $1.43
Subscribe for More Information
15:26 EDTCACINotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Hewlett-Packard (HPQ), consensus 89c; L Brands (LB), consensus 62c; Synopsys (SNPS), consensus 60c; CACI International (CACI), consensus $1.43; Semtech (SMTC), consensus 39c; Popeyes Louisiana Kitchen (PLKI), consensus 39c; America's Car-Mart (CRMT), consensus 60c.
August 19, 2014
11:27 EDTFEYEFireEye drops sharply, levels to watch
In the last 15 minutes the shares have taken a sharp turn lower, lead by a large block trade of 4.89M shares. At the current price of $27.96, the stock is down over 2.9%. Next support at current price is at $27.25. Resistance is at $28.81.
09:21 EDTMNKMallinckrodt now a component of the S&P 500 Index
The inclusion comes following the completion of Mallinckrodt’s acquisition of Questcor Pharmaceuticals last week. In addition to increasing the market capitalization of Mallinckrodt, the combination has significantly strengthened the company’s balance sheet, cash generation and leverage position.
August 18, 2014
17:37 EDTLLYFDA grants tentative approval for Lilly, Boehringer Basaglar insulin
Subscribe for More Information
11:41 EDTLLYCubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:41 EDTFEYECommunity Health discloses personal data compromised in cyber attack
Earlier today, Community Health (CYH) disclosed in a filing that in July Community Health Systems confirmed that its computer network was the target of an external, criminal cyber attack that the company believes occurred in April and June. The company and its forensic expert, Mandiant, a FireEye company (FEYE), believe the attacker was an “Advanced Persistent Threat” group originating from China who used highly sophisticated malware and technology to attack the company’s systems.The company has been informed by federal authorities and Mandiant that this intruder has typically sought valuable intellectual property, such as medical device and equipment development data. However, in this instance the data transferred was non-medical patient identification data related to the company’s physician practice operations and affected approximately 4.5M individuals who, in the last five years, were referred for or received services from physicians affiliated with the company. The company has confirmed that this data did not include patient credit card, medical or clinical information; the data is, however, considered protected under the Health Insurance Portability and Accountability Act because it includes patient names, addresses, birthdates, telephone numbers and social security numbers. The company does not believe this incident will have a material adverse effect on its business or financial results.
08:16 EDTONNNON Semiconductor sees Aptina slightly accretive to non-GAAP net income for Q3
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use